Adma Biologics (ADMA) Inventory Average (2012 - 2026)
Adma Biologics' (ADMA) quarterly Inventory Average came in at $201.6 million in Q4 2025, up 17.86% YoY from $171.0 million in Q4 2024, and up 3.86% on a QoQ basis from $194.1 million in Q3 2025.
Adma Biologics (ADMA) Inventory Average (2012 - 2026) Analysis & Trends
Adma Biologics (ADMA) has 11 years of Inventory Average data on file, last reported at $201.6 million in Q4 2025.
- Quarterly Inventory Average rose 17.86% year-over-year to $201.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $201.6 million (up 17.86% YoY) and the FY2025 annual result came in at $188.4 million, up 9.78% from the prior year.
- Inventory Average advanced to $201.6 million in Q4 2025, from $194.1 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $201.6 million in Q4 2025 to a low of $87.8 million in Q1 2021.
- A 5-year average of $155.5 million and a median of $163.4 million in 2022 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2021 — Inventory Average jumped 66.75% — and 2025, when it decreased 2.34%.
- Tracing ADMA's Inventory Average over 5 years: stood at $119.4 million in 2021, then jumped by 36.57% to $163.1 million in 2022, then increased by 3.01% to $168.0 million in 2023, then grew by 1.79% to $171.0 million in 2024, then advanced by 17.86% to $201.6 million in 2025.
- The last three Inventory Average figures came in at $201.6 million (Q4 2025), $194.1 million (Q3 2025), and $181.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn | 222.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 222.89 Mn |
| Dec 31, 2025 | 201.57 Mn |
| Sep 30, 2025 | 194.07 Mn |
| Jun 30, 2025 | 181.83 Mn |
| Mar 31, 2025 | 171.21 Mn |
| Dec 31, 2024 | 171.02 Mn |
| Sep 30, 2024 | 175.80 Mn |
| Jun 30, 2024 | 178.77 Mn |
| Mar 31, 2024 | 175.32 Mn |
| Dec 31, 2023 | 168.01 Mn |
| Sep 30, 2023 | 162.45 Mn |
| Jun 30, 2023 | 162.88 Mn |
| Mar 31, 2023 | 163.63 Mn |
| Dec 31, 2022 | 163.10 Mn |
| Sep 30, 2022 | 154.49 Mn |
| Jun 30, 2022 | 142.61 Mn |
| Mar 31, 2022 | 131.94 Mn |
| Dec 31, 2021 | 119.42 Mn |
| Sep 30, 2021 | 106.91 Mn |
| Jun 30, 2021 | 96.92 Mn |